DURELIMMU Priority claimed from 15/04/2020; Application No. : 88873082 ;United States of America
Goods or services claimed
Pharmaceutical preparations for human use. This application is for a word mark without regard to its graphical form..
Similar marks in class 5, same issue
- DUALAGO Priority claimed from 15/04/2020; Application No. : 88873083 ;United States of America named · Bristol-Myers Squibb Company
- NYRLUQ Priority claimed from 15/09/2022; Application No. : 97592430 ;United States of America similar · Orasis Pharmaceuticals LTD
- Priority claimed from 05/08/2020; Application No. : 90094836 ;United States of America similar · [International Registration No. : 1562840]
- ZIMRIXBY Priority claimed from 10/08/2022; Application No. : 97542559 ;United States of America similar · Fresenius Kabi Deutschland Gmbh
- VEOZAH Priority claimed from 30/09/2022; Application No. : 97614529 ;United States of America similar · Astellas Us Llc
Found by the same matcher that powers Brand Watch: identical, contained, near-spellings and sounds-alike names.
What "advertised" means for DURELIMMU Priority claimed from 15/04/2020; Application No. : 88873082 ;United States of America
Advertised is not registered. The Registry examined the application, found no bar (or the applicant overcame the objection), and published it. Registration follows only if no opposition is filed within four months, or if an opposition fails. Until the certificate issues, the applicant may use ™ but not ®. Our guide to trademark status meanings explains each stage, and how long registration takes gives realistic timelines.
Source and corrections. Details are reproduced as advertised by the Registrar of Trade Marks in the Trade Marks Journal (a public record) and may contain errors of transcription. Applicants may ask for a correction or removal of their entry by writing to mehak@trademarkindia.pro. This page is information, not legal advice and not a solicitation.